AVANOS MEDICAL, INC. Quarterly Amortization of Intangible Assets in USD from Q3 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Avanos Medical, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q3 2013 to Q3 2024.
  • Avanos Medical, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $6.4M, a 3.23% increase year-over-year.
  • Avanos Medical, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $25.3M, a 3.27% increase year-over-year.
  • Avanos Medical, Inc. annual Amortization of Intangible Assets for 2023 was $24.3M, a 2.97% increase from 2022.
  • Avanos Medical, Inc. annual Amortization of Intangible Assets for 2022 was $23.6M, a 61.6% increase from 2021.
  • Avanos Medical, Inc. annual Amortization of Intangible Assets for 2021 was $14.6M, a 24.7% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $25.3M $6.4M +$200K +3.23% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $25.1M $6.3M +$500K +8.62% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $24.6M $6.1M +$300K +5.17% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $24.3M $6.5M -$200K -2.99% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $24.5M $6.2M +$700K +12.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $23.8M $5.8M +$100K +1.75% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $23.7M $5.8M +$100K +1.75% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $23.6M $6.7M +$4.6M +219% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $19M $5.5M +$1.3M +31% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $17.7M $5.7M +$1.6M +39% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $16.1M $5.7M +$1.5M +35.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $14.6M $2.1M -$2.7M -56.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $17.3M $4.2M -$700K -14.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $18M $4.1M -$800K -16.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $18.8M $4.2M -$600K -12.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $19.4M $4.8M -$400K -7.69% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $19.8M $4.9M -$300K -5.77% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $20.1M $4.9M +$100K +2.08% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $20M $4.8M $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $20M $5.2M -$200K -3.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $20.2M $5.2M -$200K -3.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $20.4M $4.8M +$100K +2.13% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $20.3M $4.8M +$300K +6.67% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $20M $5.4M +$200K +3.85% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $19.8M $5.4M +$300K +5.88% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $19.5M $4.7M -$400K -7.84% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $19.9M $4.5M -$800K -15.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $20.7M $5.2M -$200K -3.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $20.9M $5.1M -$900K -15% Jul 1, 2017 Sep 30, 2017 10-Q/A 2018-12-17
Q2 2017 $21.8M $5.1M +$100K +2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $21.7M $5.3M +$300K +6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $21.4M $5.4M -$1.6M -22.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $23M $6M $0 0% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 $23M $5M -$1M -16.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $24M $5M -$1M -16.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 $25M $7M -$1M -12.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $26M $6M -$2M -25% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $28M $6M -$2M -25% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $30M $6M -$2M -25% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $32M $8M Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $8M +$1M +14.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $8M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 $8M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q3 2013 $7M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.